Objective: Nitric oxide exerts its cardiovascular actions at least in part by modulation of the sympathetic vasoconstrictor tone. There is increasing evidence that nitric oxide inhibits central neural sympathetic outflow, and preliminary evidence suggests that it may also modulate peripheral sympathetic vasoconstrictor tone. Methods: To test this latter concept, in six subjects having undergone thoracic sympathectomy for hyperhydrosis, we compared the vascular responses to systemic L-NMMA infusion (1mg / kg / min over 10 min) in the innervated and the denervated limb. We also studied vascular responses to the infusion of the non-nitric-oxide-dependent vasoconstrictor phenylephrine. Results: L-NMMA infusion evoked a roughly 3-fold larger increase in vascular resistance in the denervated forearm than in the innervated calf. In the denervated forearm, vascular resistance increased by 58610 percent (X6SE), whereas in the innervated calf it increased only by 2166 percent (P,0.01, forearm vs. calf). This augmented vasoconstrictor response was specific for L-NMMA, and not related to augmented non-specific vasoconstrictor responsiveness secondary to sympathectomy, because phenylephrine infusion increased vascular resistance similarly in the denervated forearm and the innervated calf (by 2467, and 2968 percent, respectively). The augmented vasoconstrictor response was related specifically to denervation, because in control subjects, the vasoconstrictor responses to L-NMMA were comparable in the forearm and the calf. Conclusions: These findings indicate that in the absence of sympathetic innervation, the vasoconstrictor responses to nitric oxide synthase inhibition are augmented.
Introduction
its cardiovascular actions at least in part by modulating the sympathetic vasoconstrictor tone [6] [7] [8] . Regarding the Nitric oxide which is synthesized by the endothelium latter, two concepts have been proposed. First, in both from the amino acid L-arginine by the ubiquitous enzyme animals [6] [7] [8] , and humans [9] , nitric oxide inhibits central nitric oxide-synthase [1] , has emerged as a key regulatory neural vasoconstrictor outflow. More recently, it has been mechanism of blood pressure and vasomotor tone in both suggested that nitric oxide also may modulate sympathetic animals and humans [2, 3] . While there is abundant evitone peripherally [10] , as evidenced by the suppression of dence that nitric oxide exerts its vasodilator action at least the L-NMMA induced pressor effect by sympathectomy in in part by a direct effect at the vascular smooth muscle cell anesthetized, paralyzed, baroreflex-denervated cats [11] . [4] , more recent evidence suggests that nitric oxide which To test this latter concept, we examined vasoconstrictor is also synthesized in the central nervous system [5] , exerts responses to systemic L-NMMA infusion in the innervated calf and the denervated forearm in subjects having undergone thoracic sympathectomy for hyperhydrosis. We com- Vasoconstrictor responses to immersion of the hand in ice All subjects were normotensive, were taking no medicawater in the sympathetically denervated forearm were tions, and had no evidence of metabolic or cardiovascular abolished; during the second minute of the cold pressor disease. The studies were performed in the morning after test, vascular resistance had increased by 48620 percent in an overnight fast. The subjects were asked to abstain from the innervated limb, whereas it had decreased by 1765 alcohol, caffeine and tobacco for at least 24 h before each percent in the denervated limb (P,0.02 innervated vs. study. The investigation conforms with the principles denervated limbs). outlined in the Declaration of Helsinki. The experimental Protocol 2: Cardiovascular effects of equipressive dose protocol was approved by the Institutional Review Board of phenylephrine infusion. Four of the subjects having on Human Investigation, and all subjects provided written undergone thoracic sympathectomy returned for this study informed consent.
during which, after 30 min of normal saline infusion (1 ml / min), they received a phenylephrine infusion titrated at 2.2. General procedures a dose to match the increase in arterial pressure observed during the L-NMMA infusion. Hemodynamic measureThe subjects were studied in the supine position. Heart ments were recorded during two 5 min periods of the rate (electrocardiogram) and blood pressure (Finapres) saline and the phenylephrine infusion. were measured continuously. For drug infusion, an intravenous catheter was inserted in an antecubital vein.
Data analysis 2.Measurement of muscle blood flow
Mean arterial pressure was calculated as diastolic presLimb blood flow was measured by venous occlusion sure plus 1 / 3 pulse pressure. Vascular resistance was plethysmography, using mercury-in-Silastic strain gauges.
determined as mean arterial pressure in mmHg divided by The limbs were elevated 10 to 15 cm above the level of the blood flow in ml / min per 100 ml of tissue. The measureright atrium to collapse the veins. The circulation to the ments of limb blood flow, arterial pressure, and heart rate hand and the foot was arrested by inflating a cuff around that were collected over 5 min periods were averaged to a the wrist and the ankle during blood flow determinations, single value. which were performed at 15-second intervals over a 5-min Statistical analysis was performed using paired and period. [12] unpaired two-tailed t-tests, as appropriate. A P value ,0.05 was considered to indicate significance. Unless 2.4. Drugs stated otherwise, data are expressed as means6SE.
Drugs were dissolved in physiological saline immediately before use. L-NMMA, L-arginine, and D-arginine 4. Results were obtained from Clinalfa (Laufelfingen, Switzerland), and phenylephrine from Winthrop Pharmaceuticals
In the subjects having undergone thoracic sympathec-(Zurich, Switzerland).
tomy, the base-line vascular resistance (Table 1) in the denervated forearm and the innervated calf was compar-2.5. Experimental protocols able (P50.9). The base-line vascular resistance in the denervated forearm was also not different (P50.3) from Protocol 1: Cardiovascular effects of L-NMMA infusion.
the baseline vascular resistance in the control subjects. After instrumentation the subjects rested quietly for 30
Figs. 1 and 2 show that L-NMMA infusion evoked a min. They then received sequential infusions of normal roughly 3-fold larger increase in vascular resistance in the saline (1 ml / min for 20 min), L-NMMA (1mg / kg / min for denervated forearm than in the innervated calf. In the 10 min), D-arginine (100 mg / kg over 10 min), and Lforearm, vascular resistance increased by 58610 percent 
a Values are means6SE for six subjects with sympathectomy (except for phenylephrine and D-arginine infusion; n54), and five control subjects. b P,0.05 vs. corresponding base-line. c P,0.01 vs. corresponding base-line.
during L-NMMA infusion whereas in the calf, it increased studies suggest that it does so, at least in part, by only by 2166 percent (P,0.001, forearm vs. calf). The modulating sympathetic vasoconstrictor outflow [15] . Here L-NMMA induced vasoconstriction was reversed by L- we used subjects having undergone thoracic sympathecarginine, but not by D-arginine, infusion (Table 1) . In tomy for hyperhydrosis, to probe the role of the peripheral contrast to L-NMMA, infusion of an equipressive dose of sympathetic nervous system in the modulation of the phenylephrine increased the vascular resistance comparabvascular responsiveness to nitric oxide synthase inhibition. ly in the denervated and the innervated limb (by 2463 and
We found that sympathectomy markedly potentiated the 2667 percent, respectively; P.0.5, forearm vs. calf).
vasoconstrictor effect of L-NMMA infusion. The L-NMMA In the control subjects, the vascular responses to Linduced vasoconstrictor effect was almost three times NMMA infusion in the forearm and the calf were comparlarger in the denervated than in the innervated limb. These able (Table 1) .
findings provide the first evidence for an important interplay between the peripheral sympathetic nervous system and the L-arginine-nitric-oxide system in the regulation of 5. Discussion the vascular tone in humans, and indicate that sympathetic innervation attenuates the vasoconstrictor effect of nitric Nitric oxide has emerged as a key regulatory mechanism oxide synthase inhibition. of vasomotor tone and arterial pressure [2, 3] . Recent
The augmented L-NMMA-induced vasoconstrictor effect sympathetic denervation potentiates the vasoconstrictor effects of nitric oxide synthase inhibition. We do not know yet the underlying mechanism(s) by which sympathetic innervation attenuates the L-NMMA induced vasoconstriction. It is possible that in denervated limbs, the contribution of nitric oxide to local vascular resistance regulation may be augmented, leading to augmented vasoconstrictor responses during L-NMMA infusion. Alternatively, in innervated limbs, neuronal, non-nitric-oxide-dependent vasodilator mechanisms may attenuate the vasoconstrictor effects of nitric oxide synthase inhibition.
